Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,732,014
-$485,882 QoQ
Shares Held
154,984
+3.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#721
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Csenge Advisory Group holds $34,699,600 across 10 Drug Manufacturers - General names. PFE ranks #5 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,327 | $6,389,364 | |
| 2 | ABBV |
AbbVie Inc.
|
25,158 | $6,330,759 | |
| 3 | JNJ |
Johnson & Johnson
|
18,196 | $4,621,238 | |
| 4 | AMGN |
Amgen Inc
|
10,362 | $3,752,287 | |
| 5 | PFE |
Pfizer Inc
This page
|
154,984 | $3,732,014 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
22,416 | $2,832,037 | |
| 7 | NVS |
Novartis AG
|
16,110 | $2,524,759 | |
| 8 | GSK |
GSK plc
|
41,506 | $2,175,744 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,732,014 | 154,984 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,217,896 | 150,210 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,794,511 | 152,390 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,480,083 | 136,581 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,143,882 | 88,444 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,135,376 | 84,269 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,036,129 | 39,055 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,318,882 | 45,573 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,312,262 | 46,900 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $1,265,261 | 45,595 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,409,702 | 48,965 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,000,980 | 60,325 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,058,371 | 56,117 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $2,338,370 | 57,313 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $2,940,714 | 57,391 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,503,640 | 57,213 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $3,172,224 | 60,504 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,770,160 | 53,509 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,930,828 | 49,633 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,857,300 | 43,183 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $1,943,628 | 49,633 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,054,437 | 29,104 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,373,638 | 37,317 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,391,589 | 37,918 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,201,857 | 36,754 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $698,723 | 21,407 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||